The Drug and Alcohol Health Integration Team (HIT) is a team of public health experts, academics, doctors and other professionals, working together to reduce the harm that can be caused by alcohol and substance use.
Excessive alcohol use is the third leading risk factor for morbidity in Western Europe. Liver disease is the fifth most common cause of death in the UK and is on the increase, primarily caused by excessive drinking and hepatitis C (HCV). Over 85 per cent of HCV in the UK is due to injecting drug use, and opiate-related deaths are a major contributor to premature mortality.
2 December 2019
A new study published today [Wednesday 6 November] in Psychological Medicine and led by University of Bristol researchers has found that tobacco smoking may increase your risk of developing depression and schizophrenia.
2 December 2019
Researchers at the University of Bristol have found evidence of an association between generalised anxiety disorder at age 18 and harmful drinking three years later, thanks to the long-term health study Children of the 90s.
18 November 2019
Work conducted by our Drug and Alcohol HIT members has led to ‘low dead space’ syringes being phased into Bristol’s needle and syringe programme.
13 May 2019
Health Integration Teams (HITs) are set to benefit from £176k of investment from Bristol Health Partners in 2019-20. HITs requested funding from the partnership for a wide variety of projects, with the majority receiving funding.
26 April 2019
Kyla Thomas, Thara Raj and Tim Williams, Directors of the Drug and Alcohol Health Integration Team (HIT), reflect on their team’s work in 2018-19....
17 April 2019
Dr Kyla Thomas has been jointly awarded the Society for the Study of Addiction (SSA) Fred Yates prize for researcher of the year 2019.
31 January 2019
More than 70 people gathered to hear about a project to produce materials to promote the use of safer low dead space injecting equipment on Thursday 24 January.
3 December 2018
New posters, a booklet and an animation, co-designed by service users from Bristol Drugs Project, are being launched on 24 January to promote the benefits of low dead space injecting equipment for people who inject drugs, alongside broader harm reduction...
15 June 2018
Bristol Health Partners Health Integration Teams (HITs) have attracted nearly £4.7 million in funding to the local health system in 2017-18.
18 May 2018
Olly Watson, Senior Project Manager at Bristol Health Partners, on the impact of Megan Davies's work with us. Megan has been working with Bristol Health Partners on an internship for the past three months....
15 May 2018
Megan Davies, who has been working with Bristol Health Partners on an internship for the past three months, reflects on what she's learned during her time in Bristol.
24 April 2018
Kyla Thomas, Leonie Roberts, Katherine Williams and Tim Williams, Directors of the Drug and Alcohol Health Integration Team (HIT), reflect on their team’s work in 2017-18.
7 February 2018
Five Health Integration Teams (HITs) presented their work aimed at keeping people out of hospital at a special lunchtime seminar on 5 February, to commissioners, project managers, researchers and people from the voluntary sector.
19 May 2017
Leonie Roberts, Matthew Hickman, Katherine Williams and Tim Williams, Directors of the Drug and Alcohol Health Integration Team (HIT), reflect on their team’s work in 2016-17.
27 March 2017
Health Integration Teams (HITs) have brought £3,988,121 of funding to the region since July 2016. Some of these awards are for research, while others are for service innovation.
26 October 2016
People who inject drugs support the use of new, safer ‘low dead space’ syringes, NIHR-funded researchers from the University of Bristol have found.
9 September 2016
Healthwatch Bristol has published a guide for patients and the public, to help them find out how they can make their voices heard on local mental health services.
11 July 2016
Six projects relating to the work of Bristol Health Partners Health Integration Teams (HITs) are being taken forward by NIHR CLAHRC West from their 2016 project call.
1 July 2016
The results of NIHR CLAHRC West's preliminary evaluation of the ‘Health Integration Team’ model have been published in BMC Health Services Research.
27 June 2016
Our 2015-16 annual review was launched at our annual Health Integration Team (HIT) conference on 17 June. The Bristol Health Partners annual review showcases the work of the partnership and includes updates from most of our 20 HITs and a round-up of the...
18 May 2016
An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV). HCV is an important cause of liver cancer and is transmitted through blood to blood contact.
8 March 2016
The NIHR CLAHRC West project, in collaboration with the Addictions Health Integration Team, examining whether a new ‘low dead space’ syringe would be acceptable to people who inject drugs, has found that users support use of the new syringe.
16 September 2015
Patients who start treatment for dependence on opioids are five times as likely to die in the first four weeks when they are prescribed the most commonly used treatment, methadone, than with an alternative treatment, buprenorphine, a study by researchers...
27 May 2015
Professor Matt Hickman, Barbara Coleman and Dr Tim Williams, Directors of the Addictions Health Integration Team (HIT), give an update on their work in 2014-15.
29 January 2015
The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) has announced the first round of research projects that it will be working on in the first part of 2015.
10 December 2014
At the time of year where many of us will be feeling the effects of over indulgence, the work of the Addictions Health Integration Team (HIT), which focuses on reducing the harm of excessive alcohol and substance misuse, feels especially relevant.
7 May 2014
A new Health Integration Team (HIT) looking at the treatment, management and prevention of alcohol and substance misuse has been given the green light by the Bristol Health Partners Executive Group.